Ignite Creation Date:
2024-05-05 @ 7:38 PM
Last Modification Date:
2024-10-26 @ 9:51 AM
Study NCT ID:
NCT00703833
Status:
COMPLETED
Last Update Posted:
2015-11-01
First Post:
2008-06-22
Brief Title:
A Study of MK0777 Gel Extrusion Module GEM in the Treatment of Outpatients With Generalized Anxiety Disorder 0777-019
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Study Overview
Official Title:
A Double-Blind Multicenter Placebo-Controlled Study of MK0777 Gel Extrusion Module GEM 15 mg bid in the Treatment of Outpatients With Generalized Anxiety Disorder
Status:
COMPLETED
Status Verified Date:
2015-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study will look at the effectiveness of MK0777 in patients with Generalized Anxiety Disorder
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2007_630 | None | None | None |
| MK0777-019 | None | None | None |